More recent studies have identified novel roles of p53 in regulation of both innate and adaptive immune responses with potential non-cell-autonomous influences on tumor immunology [39, 40], including upregulation of PD-L1 and PD-1H [17, 41] and suppression of pro-inflammatory cytokine secretion [42, 43]. The gene discussed is TP53; the disease is neoplasm.